Serratia peptidase or serrapeptase is a proteolytic enzyme produced by the Serratia bacterium which lives in the intestine of the silkworm. Serrapeptase has been used successfully for over 30 years in Europe and Asia to reduce pain, inflammation and excess mucus secretion. More than 40 clinical studies have shown beneficial effects.

¤ Clinical studies show that it is effective across a whole range of inflammatory diseases, particularly in treating trauma-induced oedema. Serrapeptase has anti-inflammatory properties similar to those of salicylates, ibuprofen and non-steroidal anti-inflammatories (NSAIDs).

¤ It has been successfully used to treat inflammatory diseases of the ear, nose and throat. In particular, studies have highlighted its benefits in the treatment of chronic sinusitis where it improves the elimination of bronchopulmonary secretions (mucus).

¤ It boosts the activity of antibiotics and fights bacteria resistance.

¤ It is effective in the treatment of cystic breast disease.

¤ Serrapeptase digests dead tissue – this is how it releases the silkworm from its cocoon. Serrapeptase can digest blood clots, the fibrous layers which make up atheromatous plaque and cysts. The German doctor Hans Nieper has used it to treat arterial blockages and in particular, advises the use of this enzyme to treat blocked carotid arteries when conventional surgery is too risky. Doppler tests conducted after one year’s treatment showed an excellent improvement in blood circulation in the carotid arteries.